Concepedia

Publication | Closed Access

Phase II study of fulvestrant (faslodex®) in castration resistant prostate cancer

DOI

28

Citations

34

References

2008

Year

Manpreet Chadha, Umeer Ashraf, David Lawrence, Lili Tian, Ellis Levine, C. Silliman, Paul Escott, Valencia Payne, Donald L. Trump
The Prostate

Abstract

Fulvestrant was well tolerated but failed to produce clinical or PSA response in men with CRPC.

References

YearCitations

Page 1